The detection of acute lymphoblastic cancer (ALL) is critical for timely diagnosis and treatment. In this study, we propose a novel approach to enhance ALL detection using transfer learning techniques from YOLOv9 to TensorFlow, facilitating real-time application on mobile devices. Leveraging the robustness of YOLOv9 and the versatility of TensorFlow, we fine-tune the pre-trained model to optimize performance for ALL detection. The adapted model is then integrated into a mobile application, enabling users to perform real-time ALL detection using their smartphones. Our results demonstrate the efficacy of the proposed system in accurately identifying ALL cells, with a detection rate of 98% in one scenario and 100% in another. This research represents a significant step forward in leveraging advanced computer vision technologies for mobile healthcare applications, ultimately improving patient outcomes and healthcare accessibility.
No takes yet. Share an insight, caveat, or question.
Elhalid et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: